4
Changes in Ownership
TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-22-008409
Exec. VP, European Commercial sold 13,135 shares at $9.06 ($119,010)
- Exec. VP, European Commercial acquired 13,135 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Daniell Richard · Exec. VP, European Commercial
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-02-09 | Exercise or conversion : show line 1 in the form | +13,135 | 33,415 | D | ||
| 2022-02-09 | Sale : show line 2 in the form | −13,135 | $9.06 | $119,010 | 20,280 | D |
| Open-market sales · 13,135 sh · avg $9.06 · $119,010 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-02-09 | Exercise or conversion : show line 3 in the form Restricted Share Units | −13,135 | 0 | D |
| 2022-02-08 | Grant or award : show line 4 in the form Restricted Share Units | +43,358 | 43,358 | D |
Loading xslF345X03/doc4.xml…